Month: <span>April 2017</span>

Home / 2017 / April
Post

Risks of diabetics fasting during Ramadan: Hypoglycemia rates with insulin pump v. injections

A new study examining the risk of fasting during Ramadan for people with Type 1 Diabetes compared blood glucose levels in 2 groups of people: 1.Patients taking insulin pump therapy. 2.Patients taking multiple daily insulin injections. The researchers report their findings in Diabetes Technology & Therapeutics. (DTT). Researchers compared blood glucose data in these two...

Post

First photo active drug for pain treatment

A team of the Institute of Neurosciences of the University of Barcelona has participated in the design of the first light-activated drug, JF-NP-26, for the treatment of pain, according to a study with animal models published in the journal eLife. The new study is conducted by the teams led by Professor Francisco Ciruela, from the...

Post

Benefits and harms of osteoporosis medications unclear for patients with CKD

More research is needed to determine the benefits and harms of osteoporosis medications on bone mineral density (BMD), fracture risk, and safety among patients with chronic kidney disease (CKD). This is important because complications of CKD include weak bones and increased fracture risk. The results of a systematic review and meta-analysis are published in Annals...

Post

Taking a combination of painkillers and gastric protection damages the intestines

Patients suffering from inflammatory diseases are often prescribed NSAIDs. They are also prescribed PPI (Proton pump inhibitor) to protect their stomach. In a joint study, clinical pharmacologist Markus Zeitlinger and gastroenterologist Werner Dolak from MedUni Vienna showed that this combination of medication can result in inflammation in the small intestine. However, if an additional antibiotic...

Post

Scientists Discover New Class of Anti-Diabetes Compounds that Reduce Liver Glucose Production

JUPITER, FL – March 27, 2017 – Scientists may have found a new tool for studying—and maybe even treating—Type 2 diabetes, the form of diabetes considered responsible for close to 95 percent of cases in the United States. A team of scientists from the Florida campus of The Scripps Research Institute (TSRI), Dana-Farber Cancer Institute,...

Post

Scientists unpack how Toxoplasma infection is linked to neurodegenerative disease

GLT-1, a glutamate transporter, soaks up glutamate (a neurotransmitter) released by neurons and converts it back into a safer substance. Toxoplasma gondii, a protozoan parasite about five microns long, infects a third of the world’s population. Ingested via undercooked meat or unwashed vegetables, the parasite infects 15-30 percent of the US population. In France and...

Post

Homing System Delivers Drugs to Specific Neurons

Biomedical engineers have developed a way to deliver drugs to specific types of neurons in the brain, providing extraordinary ability to study neurological diseases and also a promising pathway to treat them. Drugs are the tool of choice for studying the connections between neurons and continue to be the mainstream treatment for neurological disease. But...

Post

Cause of an inherited neurological disorder discovered

Researchers at the University of Liverpool have identified the basis for how a single gene mutation can cause a rare neurological movement disorder known as dystonia. Dystonia can result from an injury or can be an inherited disorder in which patients progressively develop from childhood uncontrollable muscle contractions leading to repetitive movements and awkward and...

Post

Where does your blood actually come from?

Blood cells. Scientists at Lund University in Sweden have developed a new understanding of how the first blood cells form during human development as they transition from endothelial cells to form blood cells of different types. Using a laboratory model of human stem cell development and by looking at the expression of blood cell and...

Post

Risks of diabetics fasting during Ramadan: Hypoglycemia rates with insulin pump v. injections

A new study examining the risk of fasting during Ramadan for people with type 1 diabetes compared blood glucose control and the rates of hypoglycemia and hyperglycemia between users of insulin pump therapy versus multiple daily insulin injections. The researchers report their findings in Diabetes Technology & Therapeutics(DTT). Reem Alamoudi, MD, MHSc, Imam Abdulrahman Bin Faisal...